Research Square (Research Square),
Journal Year:
2022,
Volume and Issue:
unknown
Published: Nov. 10, 2022
Abstract
Background:
Cardiac
Myxoma
(CM)
is
a
primary
tumor
of
heart.
Its
origins,
why
the
occurrence
cardiac
tumors
extremely
rare
and
how
it
may
be
related
to
limited
regenerative
potential,
these
aspects
are
not
yet
entirely
known.
This
study
investigates
key
genes/TFs
signaling
pathways
advance
our
understanding
important
questions.
Methods:
Databases
including
PubMed,
MEDLINE,
Google
Scholar
were
searched
for
published
articles
without
any
date
restrictions,
involving
myxoma,
genes/TFs/signaling
their
roles
in
cardiogenesis,
proliferation,
differentiation,
interactions
tumorigenesis,
with
focus
on
cardiomyocytes.
Results
:
The
genetic
landscape
governed
by
very
tight
control
between
proliferation
differentiation-related
genes/TFs/pathways.
myxoma
originates
possibly
as
consequence
dysregulations
gene
expression
differentiation
regulators
Tbx5,
GATA4,
HAND1/2,
MYOCD,
HOPX,
BMPs.
Such
switch
cardiomyocytes
into
progenitor-like
state
development
dysregulating
Isl1,
Baf60
complex,
Wnt,
FGF,
Notch,
Mef2c
others.
Nkx2-5
MSX2
contribute
both
Progenitor
Cells
(CPCs)
serve
based
microenvironment
direction
cell
circuitry
tumorigenesis.
limit
progression
tumorigenesis
has
massive
over
CPCs.
type-specific
programming
plays
governing
role
controlling
potential.
Conclusion
have
proliferative
They
survive
long
periods
time
tightly
maintain
genes
such
GATA4
that
interact
suppressors
(TS)
exert
TS
like
effect.
total
effect
exerts
responsible
benign
nature
tumors.
prevents
But
this
also
limits
potential
develops
which
revert
cells
towards
state,
hallmark
CM.
CM
carney
complex
signifies
cells.
Frontiers in Bioscience-Landmark,
Journal Year:
2024,
Volume and Issue:
29(4), P. 145 - 145
Published: April 9, 2024
Sodium-glucose
cotransporters
2
(SGLT2)
are
high-capacity,
low-affinity
transporters,
expressed
mainly
in
the
early
portion
of
proximal
renal
tube,
mediating
up
to
90%
glucose
uptake,
while
SGLT1
receptors
found
small
intestine,
facilitating
absorption.
SGLT2
inhibitors
(SGLT2i)
originally
emerged
as
agents
for
treatment
type
diabetes
mellitus;
however,
they
soon
demonstrated
remarkable
cardio-
and
renoprotective
actions
that
led
their
licensed
use
heart
failure
chronic
kidney
disease,
regardless
diabetic
status.
Cardiovascular
remodelling
represents
an
umbrella
term
encompasses
changes
occur
cardiovascular
system,
from
molecular
cellular
level,
tissue
organs
after
local
injury,
stress,
or
pressure.
SGLT
modulation
has
been
shown
positively
affect
many
these
observed
during
pathological
remodelling.
Among
different
pathophysiological
mechanisms
contribute
adverse
remodelling,
various
stem
progenitor
cells
have
be
involved,
through
alterations
number
function.
Recent
studies
examined
effects
SGLT2i
on
cell
populations
more
specifically
endothelial
(EPCs).
Although
some
no
significant
effect,
others
showed
can
modulate
morphology
function
EPCs.
These
preliminary
observations
effect
EPCs
may
responsible
beneficial
gliflozins
and,
by
extension,
disease.
The
purpose
this
narrative
review
is
critically
discuss
recent
evidence
cardioprotective
SGLT2is,
context
cardiac
Biomedicine & Pharmacotherapy,
Journal Year:
2022,
Volume and Issue:
158, P. 114156 - 114156
Published: Dec. 28, 2022
Cardiovascular
diseases
(CVDs)
and
neurological
are
widespread
with
substantial
rates
of
morbidity
mortality
around
the
world.
For
past
few
years,
preventive
effects
Chinese
herbal
medicine
on
CVDs
have
attracted
a
great
deal
attention.
Icariin
(ICA),
main
constituent
Epimedii
Herba,
is
flavonoid.
It
has
been
shown
to
provide
neuroprotection,
anti-tumor,
anti-osteoporosis,
cardiovascular
protection.
The
endothelial
protection,
anti-inflammatory,
hypolipidemic,
antioxidative
stress,
anti-apoptosis
properties
ICA
can
help
stop
progression
diseases.
Therefore,
our
review
summarized
known
mechanisms
related
studies
in
prevention
treatment
cardio-cerebrovascular
(CCVDs),
better
understand
its
therapeutic
potential.
Oncology Reports,
Journal Year:
2022,
Volume and Issue:
49(2)
Published: Dec. 13, 2022
Cervical
cancer,
one
of
the
most
common
malignancies,
has
a
poor
survival
rate.
The
identification
more
biomarkers
for
cervical
cancer
diagnosis
and
therapy
is
urgently
needed.
Plasminogen
activator
urokinase
(PLAU)
exerts
multiple
biological
effects
in
various
physiological
pathological
processes;
however
role
PLAU
progression
not
fully
understood.
In
present
study,
involvement
transcriptional
regulation
were
explored.
expression
was
first
analyzed,
found
to
be
overexpressed.
vitro
experiments
demonstrated
that
migration
invasion
HeLa
HT3
cells
significantly
suppressed
by
knockdown.
Additionally,
core
promoter
confirmed,
transcription
factor
YinYang
1
(YY1)
regulate
mRNA
expression.
Overall,
study
elucidated
direct
association
between
suggesting
YY1/PLAU
axis
as
potential
novel
therapeutic
target
cancer.
Revista Portuguesa de Cardiologia,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 1, 2024
The
development
of
cardiac
fibrosis
(CF)
and
hypertrophy
(CH)
can
lead
to
heart
failure.
Mesenchymal
stem
cells
(MSCs)
have
shown
promise
in
treating
diseases.
However,
the
relationship
between
MSCs
splicing
factor
arginine/serine
rich-3
(SFRS3)
remains
unclear.
In
this
study,
our
objectives
are
investigate
effect
on
SFRS3
expression,
their
impact
CF
CH.
Additionally,
we
aim
explore
function
overexpression
angiotensin
II
(Ang
II)-treated
fibroblasts
(CFBs)
myocytes
(CMCs).
Frontiers in Cardiovascular Medicine,
Journal Year:
2023,
Volume and Issue:
10
Published: March 30, 2023
Adverse
cardiac
remodeling
after
acute
myocardial
infarction
is
the
most
important
pathological
mechanism
of
heart
failure
and
remains
a
major
problem
in
clinical
practice.
Cardiac
macrophages,
derived
from
tissue
resident
macrophages
circulating
monocyte,
undergo
significant
phenotypic
functional
changes
following
injury
play
crucial
roles
inflammatory
response
repair
response.
Currently,
numerous
studies
indicate
that
epigenetic
regulatory
factors
transcription
can
regulate
reparative
genes
timely
conversion
into
then
alleviate
remodeling.
Accordingly,
targeting
transcriptional
regulation
may
be
promising
option
for
treatment.
In
this
review,
we
not
only
summarize
origin
function
but
more
importantly,
describe
failure,
aiming
to
provide
potential
therapeutic
target
failure.
BMC Cancer,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Dec. 18, 2023
Abstract
Background
Cardiac
Myxoma
is
a
primary
tumor
of
heart.
Its
origins,
rarity
the
occurrence
cardiac
tumors
and
how
it
may
be
related
to
limited
regenerative
potential,
are
not
yet
entirely
known.
This
study
investigates
key
genes/
transcription
factors
(TFs)
signaling
pathways
understand
these
important
questions.
Methods
Databases
including
PubMed,
MEDLINE,
Google
Scholar
were
searched
for
published
articles
without
any
date
restrictions,
involving
myxoma,
genes/TFs/signaling
their
roles
in
cardiogenesis,
proliferation,
differentiation,
interactions
tumorigenesis,
with
focus
on
cardiomyocytes.
Results
The
genetic
landscape
governed
by
very
tight
control
between
proliferation
differentiation-related
genes/TFs/pathways.
myxoma
originates
possibly
as
consequence
dysregulations
gene
expression
differentiation
regulators
Tbx5,
GATA4,
HAND1/2,
MYOCD,
HOPX,
BMPs.
Such
switch
cardiomyocytes
into
progenitor-like
state
development
dysregulating
Isl1,
Baf60
complex,
Wnt,
FGF,
Notch,
Mef2c
others.
Nkx2–5
MSX2
contribute
predominantly
both
Progenitor
Cells
(CPCs),
serve
based
microenvironment
direction
cell
circuitry
tumorigenesis.
limit
progression
tumorigenesis
has
massive
over
CPCs.
type-specific
programming
plays
governing
role
controlling
potential.
Conclusion
have
proliferative
They
survive
long
periods
time
tightly
maintain
genes
such
GATA4
that
interact
suppressors
(TS)
exert
TS
like
effect.
total
effect
exerts
responsible
rare
benign
nature
tumors.
prevents
But
this
also
limits
potential
develops
which
revert
cells
towards
state,
hallmark
CM.
CM
carney
complex
signifies
cells.